← Back
Neonc Technologies Holdings
NTHI · listed on Nasdaq · worth $77.77 million
$3.07
−5.83% on Nov 2
18 insider buys in the last year, $914.8K in all. None in the last two weeks.
Green dot = an insider bought red = sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
8.1M shares
28% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, four insiders bought Neonc Technologies Holdings stock and one insider sold. None of the 1 sale is marked on its filing as planned in advance; all by company executives.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
CEO, President
Amir F. Heshmatpour
Bought $135.6K on Sep 11 — 37,000 shares at $3.67, 1.2% of what they now own.
0 of 1 earlier purchase did better than the S&P 500
Chief Scientific Officer
Thomas C. Chen
Bought $130K on Aug 14 — 33,787 shares at $3.85, 5.8% of what they now own.
0 of 1 earlier purchase did better than the S&P 500
Chief Clinical Officer
Yousha Neman-Ebrahim
Bought $7.4K on Nov 20, 2025 — 1,100 shares at $6.69, 0.8% of what they now own.
0 of 1 earlier purchase did better than the S&P 500
Planned sales
Form 144 notices filed for Neonc Technologies Holdings in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
CFO Keithly Garnett filed to sell 5,000 shares on 15 Sep; sold 5,000 by 15 Sep10b5-1 plan adopted 16 Jun 2026 · Notice on SEC.gov
All reports
Every insider trade and SEC report we hold for Neonc Technologies Holdings.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
14 more with Pro →Analysts, earnings and news
Analysts' price target
$17.00 average
4 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
1 of 3 quarters above
Q2 '26−$0.58 a share−$0.41
Q1 '26−$0.38 a share
Q4 '25−$0.35 a share+$0.02